Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Virus-based gene therapy research, RNA Interference and Gene Delivery, and CAR-T cell therapy research.
Machine learning improves prediction of postoperative outcomes after gastrointestinal surgery: a systematic review and meta-analysis
Oncogenic IDH1 <sup>mut</sup> drives robust loss of histone acetylation and increases chromatin heterogeneity
Miniaturized microarray-format digital ELISA enabled by lithographic protein patterning
A road map for the treatment of pediatric diffuse midline glioma
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cells
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Consensus guidelines for the detection of immunogenic cell death
Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
Progress in gene therapy for neurological disorders
Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
Gene therapy for brain tumors: Basic developments and clinical implementation
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model